Company / Goodwill
NeoGenomics Laboratories, Inc. Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$524.3M
FY2025
5-year range
$522.8M / $527.1M
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
#82 of 136
Health Care
What the data says
At $524M, NeoGenomics Laboratories, Inc.'s goodwill ranks #82 of 136 in the Health Care sector.
Based on SEC 10-K filings.
$524M in FY2025 with a 5-year CAGR of +20.0%.
Remained stable around $524M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +0.1%
- 5-Year CAGR
- +20.0%
- 10-Year CAGR
- -
Sector benchmark
#82 of 136 in Health CareTop 60% of 136This company $524.3M Sector average $5.2B
▼
-90.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.0%, indicating consistent growth.
- In FY2025, goodwill increased 0.3% year-over-year.
- Ranks #82 out of 136 companies in the Health Care sector.
- Peak goodwill was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $524.3M | +0.3% |
| FY2024 | $522.8M | +0.0% |
| FY2023 | $522.8M | +0.0% |
| FY2022 | $522.8M | -0.8% |
| FY2021 | $527.1M | +149.7% |
| FY2020 | $211.1M | +6.3% |
| FY2019 | $198.6M | +0.4% |
| FY2018 | $197.9M | +34.6% |
| FY2017 | $147.0M | +0.0% |
| FY2016 | $147.0M | +0.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026